Physician profile
Anthony Doing
NPI 1235135708
$2,938.37
in general payments reported to CMS, 2019-2025
11 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $480 · 2022: $341 · 2023: $264 · 2024: $932 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,544.14 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $729.71 | 2019-2025 | General - Therapies |
| Asahi Intecc USA, INC. | $299.75 | 2019-2023 | Asahi Ptca Guide Wire |
| Reflow Medical INC | $101.31 | 2024 | |
| Novartis Pharmaceuticals Corporation | $94.62 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $77.22 | 2019-2023 | Xarelto |
| Abbott Laboratories | $24.13 | 2025 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.32 | 2019 | |
| Amgen INC. | $17.93 | 2020 | |
| Chiesi USA, INC. | $15.85 | 2024 | Kengreal |
| Atricure, INC. | $14.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Doing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.